Fine-tuned language model predicts stroke outcome from admission notes; meta-analysis finds 2D angiography misses half of clipped aneurysm remnants

An operating microscope on a wheeled stand with an articulated boom arm, its binocular head angled down over an empty table.

A large language model fine-tuned on admission notes predicted 90-day functional outcome after acute ischemic stroke with an area under the curve of 0.87, according to a retrospective study in Neurosurgery.

A meta-analysis of 38 studies in the Journal of Neurosurgery found remnants in 23.5% of clipped intracranial aneurysms on 3D angiography and a 51.7% false-negative rate for 2D angiography.

  • AI Nov 19, 2026
    A retrospective study in Neurosurgery fine-tuned large language models on admission notes from the NYU Langone GWTG-Stroke registry to predict functional outcome after acute ischemic stroke. A fine-tuned Llama model reached an area under the receiver operating characteristic curve (AUROC) of 0.84 on 9,485 notes for discharge outcome and 0.87 on 1,898 notes for 90-day outcome. The authors said fine-tuned models outperformed the prognostic baselines they evaluated; the study measured discrimination on past records, not effects on care.
  • Research Nov 20, 2026
    A systematic review and meta-analysis of 38 studies in the Journal of Neurosurgery estimated that 23.5% (95% CI 19% to 28.7%) of clipped intracranial aneurysms had remnants on 3D digital subtraction angiography, and that 2D angiography had a false-negative rate of 51.7% (95% CI 38.6% to 64.6%) for detecting them. Recurrence was 21.5% after incomplete clipping versus 0.7% after complete clipping (relative risk 15.7, 95% CI 7.5 to 32.7). The authors said one in four to five remnants regrows.
  • Technology Nov 19, 2026
    Spryte Medical said Nov. 19 that nOCT imaging was completed in all subjects in INSYTE, a prospective, single-arm, multicenter pivotal trial of its investigational intravascular optical imaging device in the neurovasculature, producing diagnostic-quality images longer than 50 mm against a predefined performance target of 24 mm. Imaging was associated with a change in investigator treatment decisions in more than 40% of patients, the company said, but the trial was not designed to test whether those changes improved clinical outcomes. No serious adverse events were directly attributed to the imaging, according to the release.

The weekly innovation roundup for neurosurgery, published every Sunday for the week before; every item links to its sources. Latest neurosurgery news · All specialties

Latest news

Tagged neurosurgery, from the daily briefing

  1. Embolizing the middle meningeal artery after chronic subdural hematoma treatment cut reoperations to 7.3% from 18.3% in a French trial
  2. MemorialCare adopts Rapid Aneurysm software to flag and measure suspected aneurysms on brain CTA and MRA
  3. Extended INDIGO follow-up of vorasidenib in IDH-mutant glioma presented at SNO 2026

See all the latest news